Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Aug;54(8):693–696. doi: 10.1136/thx.54.8.693

Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease

T Ishii 1, T Matsuse 1, S Teramoto 1, H Matsui 1, M Miyao 1, T Hosoi 1, H Takahashi 1, Y Fukuchi 1, Y Ouchi 1
PMCID: PMC1745535  PMID: 10413721

Abstract

BACKGROUND—Enzymes that contribute to the local detoxification in alveoli and bronchioles have an important role in the defence mechanism against tobacco smoke. It has been suggested that genetic susceptibility to smoking injury may confer a risk for the development of chronic obstructive pulmonary disease (COPD). The polymorphisms in glutathione S-transferase P1 (GSTP1), a xenobiotic metabolising enzyme, were investigated in patients with COPD.
METHODS—Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were performed to genotype GSTP1 polymorphisms in exon 5 (Ile105Val) and exon 6 (Ala114Val). Blood samples were taken from 53 patients with COPD and 50 control subjects at the Tokyo University Hospital, the Juntendo University Hospital, and the Tokyo Kenbikyoin Clinic for use in the study.
RESULTS—The proportion of GSTP1/Ile105 homozygotes was significantly higher in the patients with COPD than in the control subjects (79% vs 52%). The odds ratio for GSTP1/Ile105 homozygotes versus all other genotypes was 3.5 (95% CI 2.7 to 4.6) for COPD. Polymorphism at residue 114 of GSTP1 was not found in either group.
CONCLUSIONS—Genetic polymorphism of exon 5 of GSTP1 may be associated with COPD because the GSTP1/Ile105 genotype is predominantly found in COPD. It is suggested that the GSTP1/Ile105 genotype may be less protective against xenobiotics in tobacco smoke.



Full Text

The Full Text of this article is available as a PDF (94.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics. 1991 Nov;1(2):102–106. doi: 10.1097/00008571-199111000-00008. [DOI] [PubMed] [Google Scholar]
  2. Board P. G., Webb G. C., Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet. 1989 Jul;53(Pt 3):205–213. doi: 10.1111/j.1469-1809.1989.tb01786.x. [DOI] [PubMed] [Google Scholar]
  3. Cantlay A. M., Lamb D., Gillooly M., Norrman J., Morrison D., Smith C. A., Harrison D. J. Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol. 1995 Aug;48(4):M210–M214. doi: 10.1136/mp.48.4.m210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cantlay A. M., Smith C. A., Wallace W. A., Yap P. L., Lamb D., Harrison D. J. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax. 1994 Oct;49(10):1010–1014. doi: 10.1136/thx.49.10.1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carp H., Miller F., Hoidal J. R., Janoff A. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2041–2045. doi: 10.1073/pnas.79.6.2041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen H., Juchau M. R. Inhibition of embryonic retinoic acid synthesis by aldehydes of lipid peroxidation and prevention of inhibition by reduced glutathione and glutathione S-transferases. Free Radic Biol Med. 1998 Feb;24(3):408–417. doi: 10.1016/s0891-5849(97)00272-4. [DOI] [PubMed] [Google Scholar]
  7. Church D. F., Pryor W. A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985 Dec;64:111–126. doi: 10.1289/ehp.8564111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fletcher C. M., Pride N. B. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax. 1984 Feb;39(2):81–85. doi: 10.1136/thx.39.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977 Jun 25;1(6077):1645–1648. doi: 10.1136/bmj.1.6077.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harrison D. J., Cantlay A. M., Rae F., Lamb D., Smith C. A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol. 1997 Jul;16(7):356–360. doi: 10.1177/096032719701600703. [DOI] [PubMed] [Google Scholar]
  11. Hoffmann D., Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health. 1997 Mar;50(4):307–364. doi: 10.1080/009841097160393. [DOI] [PubMed] [Google Scholar]
  12. Huang S. L., Su C. H., Chang S. C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997 Nov;156(5):1436–1439. doi: 10.1164/ajrccm.156.5.9609138. [DOI] [PubMed] [Google Scholar]
  13. Hurst R., Bao Y., Jemth P., Mannervik B., Williamson G. Phospholipid hydroperoxide glutathione peroxidase activity of human glutathione transferases. Biochem J. 1998 May 15;332(Pt 1):97–100. doi: 10.1042/bj3320097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johansson A. S., Stenberg G., Widersten M., Mannervik B. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol. 1998 May 8;278(3):687–698. doi: 10.1006/jmbi.1998.1708. [DOI] [PubMed] [Google Scholar]
  15. Lo H. W., Ali-Osman F. Genomic cloning of hGSTP1*C, an allelic human Pi class glutathione S-transferase gene variant and functional characterization of its retinoic acid response elements. J Biol Chem. 1997 Dec 26;272(52):32743–32749. doi: 10.1074/jbc.272.52.32743. [DOI] [PubMed] [Google Scholar]
  16. Mannervik B. The isoenzymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol. 1985;57:357–417. doi: 10.1002/9780470123034.ch5. [DOI] [PubMed] [Google Scholar]
  17. Massaro G. D., Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997 Jun;3(6):675–677. doi: 10.1038/nm0697-675. [DOI] [PubMed] [Google Scholar]
  18. Murray C. J., Lopez A. D. Evidence-based health policy--lessons from the Global Burden of Disease Study. Science. 1996 Nov 1;274(5288):740–743. doi: 10.1126/science.274.5288.740. [DOI] [PubMed] [Google Scholar]
  19. Ryberg D., Skaug V., Hewer A., Phillips D. H., Harries L. W., Wolf C. R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997 Jul;18(7):1285–1289. doi: 10.1093/carcin/18.7.1285. [DOI] [PubMed] [Google Scholar]
  20. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  21. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  22. Silverman E. K., Chapman H. A., Drazen J. M., Weiss S. T., Rosner B., Campbell E. J., O'DONNELL W. J., Reilly J. J., Ginns L., Mentzer S. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1770–1778. doi: 10.1164/ajrccm.157.6.9706014. [DOI] [PubMed] [Google Scholar]
  23. Smith C. A., Harrison D. J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997 Aug 30;350(9078):630–633. doi: 10.1016/S0140-6736(96)08061-0. [DOI] [PubMed] [Google Scholar]
  24. Sundberg K., Johansson A. S., Stenberg G., Widersten M., Seidel A., Mannervik B., Jernström B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis. 1998 Mar;19(3):433–436. doi: 10.1093/carcin/19.3.433. [DOI] [PubMed] [Google Scholar]
  25. Watson M. A., Stewart R. K., Smith G. B., Massey T. E., Bell D. A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998 Feb;19(2):275–280. doi: 10.1093/carcin/19.2.275. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES